Skip to content
Screener

Replimune Group REPL Interest Expense

Interest Expense at other companies

Amgen logo
AmgenAMGN
$673M-3.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$11M+206%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$1.56M+411%
Regenxbio logo
RegenxbioRGNX
$7.79M-29.1%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$13.87M+2.5%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$1.15B+195%
Enterprise value$1.1B+199%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseDebt.

The source filing: Replimune Group’s 10-Q, filed February 3, 2026.

Filed
Feb 3, 2026, 8:12 AM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q4 2025
Accession
0001628280-26-004805
Line itemThree Months Ended December 31, 2025Three Months Ended December 31, 2024Nine Months Ended December 31, 2025Nine Months Ended December 31, 2024
Research and development incentives3413761,1381,222
Investment income2,8465,13711,25615,243
Interest expense on finance lease liability(514)(528)(1,553)(1,594)
Interest expense on debt obligations(1,466)(1,450)(4,429)(4,314)
Other (expense) income, net(580)(3,281)(865)(850)
Total other income (expense), net6272545,5479,707
Loss before income taxes$(71,241)$(65,765)$(241,034)$(172,592)
Income tax (benefit) provision(311)$575$(311)$575

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Replimune Group's interest expense?
Replimune Group (REPL) reported interest expense of $1.47M in Q4 2025.
How has Replimune Group's interest expense changed year-over-year?
Replimune Group's interest expense increased by 1.1% year-over-year, from $1.45M to $1.47M.
What is the long-term trend for Replimune Group's interest expense?
Over 3 years (2022 to 2025), Replimune Group's interest expense has grown at a 73.0% compound annual growth rate (CAGR), from $1.12M to $5.78M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about Replimune Group's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude